RIDECLAS: Delphi Classification of RICA Pathway Recommendations

Condition(s) studied

Investigational drug(s) / intervention(s)

Modified Delphi questionnaire: Sequential online questionnaires used to rate and classify proposed RICA Pathway recommendations. This is not a clinical intervention and does not involve patient care, drugs, devices, or invasive procedures.

Study summary

RIDECLAS is an observational, prospective, non-interventional consensus study using a modified Delphi methodology. The study aims to obtain expert consensus on the classification and final formulation of recommendations for the RICA Pathway, an enhanced recovery pathway for adult surgery. Participants will be healthcare professionals with experience in enhanced recovery, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. Experts will complete sequential online questionnaires. Individual responses will remain confidential, and aggregated anonymized feedback will be provided between Delphi rounds. The study does not involve patients, clinical interventions, biological samples, drugs, or medical devices.

Eligibility

Primary outcome measure(s)

• Expert consensus on RICA Pathway recommendations — Through study completion, up to 7 months
  Consensus will be assessed for each recommendation using predefined Delphi criteria. Acceptance consensus will be defined as at least 75% of ratings in the 7-9 range and no more than 15% in the 1-3 range. Rejection consensus will be defined as at least 75% of ratings in the 1-3 range and no more than 15% in the 7-9 range.

Trial sites (1)

More Universidad de Zaragoza trials in Spain

Other trials for the same condition